CVE-2025-67108

Eprosima Fast Dds vulnerability

10.0 CRITICALEPSS 0.31%

Published23 Dec 2025

Description

eProsima Fast-DDS v3.3 was discovered to contain improper validation for ticket revocation, resulting in insecure communications and connections.

CVSS 3.1 breakdown

Attack vectorNetwork

Attack complexityLow

Privileges requiredNone

User interactionNone

ScopeChanged

ConfidentialityHigh

IntegrityHigh

AvailabilityNone

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:N

Affected products

Eprosima Fast Dds3.3.0

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

References

Related CVEs

Recent high-severity vulnerabilities sharing a weakness type.

Frequently asked

Is CVE-2025-67108 being actively exploited?

CVE-2025-67108 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.31%.

How severe is CVE-2025-67108?

CVE-2025-67108 has a CVSS 3.1 base score of 10.0, rated critical. EPSS estimates a 0.31% probability of exploitation.

Which products are affected by CVE-2025-67108?

Affected products include Eprosima Fast Dds.

How do I fix CVE-2025-67108?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2025-67108 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.